A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Levocetirizine Dihydrochloride (Xyzal)

Levocetirizine Dihydrochloride blocks histamine to relieve allergy symptoms like sneezing, itching, and runny nose.

First FDA approval2011-02-24
Generic availableYes · 11 mfrs
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$44.1M in CY2024 Part D spend3.6M claims · 1.3M beneficiaries · 329 plans surveyed

Lowest NADAC
$0.055/unit
12 NDCs benchmarked, lowest of all strengths.
Average NADAC
$0.104
Across all dosage forms in distribution.
Highest NADAC
$0.354
Wide spread — brand-strength NDCs still in market.
Plans with PA
0 / 329
Zero PA friction — switching is purely formulary.

Questions a plan sponsor actually asks.

FAQPage schema12 entries indexed · 4 visible
What is Levocetirizine Dihydrochloride used for?

Levocetirizine Dihydrochloride blocks histamine to relieve allergy symptoms like sneezing, itching, and runny nose.

Is there a generic for Levocetirizine Dihydrochloride?

Yes. 12 ANDAs filed at FDA, 11 generic manufacturers currently shipping.

How much does my plan pay for Levocetirizine Dihydrochloride?

Across 329 Part D plans, Levocetirizine Dihydrochloride averages $0.104/unit (NADAC). Lowest available: $0.055/unit. Highest in distribution: $0.354/unit.

Is Levocetirizine Dihydrochloride on the FDA shortage list?

No. Levocetirizine Dihydrochloride is not currently on the FDA Drug Shortage Database.

8 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Histamine-1 Receptor Antagonist6 alternatives in D1
01
Alcaftadine
Brand: LASTACAFT
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
02
Azelastine
Brand: Azelastine Hydrochloride
$0.286Lowest NADAC
10Generic mfrs
$131.8MCY24 Part D spend
Compare →
03
Azelastine and Fluticasone
Brand: DYMISTA
$2.26Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
04
Bepotastine Besilate
Brand: Bepreve
$13.03Lowest NADAC
4Generic mfrs
$16.6MCY24 Part D spend
Compare →
05
Carbinoxamine
Brand: CARBZAH
$0.432Lowest NADAC
4Generic mfrs
$3.6MCY24 Part D spend
Compare →
06
Cetirizine
Brand: Cetirizine Hydrochloride
$0.021Lowest NADAC
9Generic mfrs
$5.5MCY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (12 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.